Marcus D. Ballinger

Person

Burlingame, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heregulin variants
- Patent number 7,563,583
- Issue date Jul 21, 2009
- Genentech, Inc.
- Marcus D Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heregulin variants
- Patent number 7,063,961
- Issue date Jun 20, 2006
- Genentech, Inc.
- Marcus D. Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibroblast growth factor receptor-immunoglobulin fusion
- Patent number 6,656,728
- Issue date Dec 2, 2003
- Chiron Corporation
- W. Michael Kavanaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic peptides having FGF receptor affinity
- Patent number 6,548,634
- Issue date Apr 15, 2003
- Chiron Corporation
- Marcus Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heregulin variants
- Patent number 6,387,638
- Issue date May 14, 2002
- Genentech, Inc.
- Marcus D. Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heregulin variants
- Patent number 6,136,558
- Issue date Oct 24, 2000
- Genentech, Inc.
- Marcus D. Ballinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Subtilisin variants capable of cleaving substrates containing basic...
- Patent number 5,837,516
- Issue date Nov 17, 1998
- Genentech, Inc.
- Marcus D. Ballinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Subtilisin variants capable of cleaving substrates containing dibas...
- Patent number 5,780,285
- Issue date Jul 14, 1998
- Genentech, Inc.
- Marcus D. Ballinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Subtilisin variants capable of cleaving substrates containing dibas...
- Patent number 5,741,664
- Issue date Apr 21, 1998
- Genentech, Inc.
- Marcus D. Ballinger
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY
- Publication number 20220016243
- Publication date Jan 20, 2022
- Genentech, Inc.
- Catherine LAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heregulin variants
- Publication number 20060183194
- Publication date Aug 17, 2006
- Genentech, Inc.
- Marcus D. Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Constructs for homogenously processed preparations of beta site APP...
- Publication number 20060019368
- Publication date Jan 26, 2006
- Marcus Ballinger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Constructs for homogenously processed preparations of beta site APP...
- Publication number 20050074456
- Publication date Apr 7, 2005
- Marcus Ballinger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fibroblast growth factor
- Publication number 20040063910
- Publication date Apr 1, 2004
- Chiron Corporation
- W. Michael Kavanaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Synthetic peptides having FGF receptor affinity
- Publication number 20040054131
- Publication date Mar 18, 2004
- Marcus Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heregulin variants
- Publication number 20030129688
- Publication date Jul 10, 2003
- Genentech, Inc.
- Marcus D. Ballinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Marcus D. Ballinger

Person

Patents Grantslast 30 patents

Heregulin variants

Heregulin variants

Fibroblast growth factor receptor-immunoglobulin fusion

Synthetic peptides having FGF receptor affinity

Heregulin variants

Heregulin variants

Subtilisin variants capable of cleaving substrates containing basic...

Subtilisin variants capable of cleaving substrates containing dibas...

Subtilisin variants capable of cleaving substrates containing dibas...

Patents Applicationslast 30 patents

METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY

Heregulin variants

Constructs for homogenously processed preparations of beta site APP...

Constructs for homogenously processed preparations of beta site APP...

Fibroblast growth factor

Synthetic peptides having FGF receptor affinity

Heregulin variants